⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL15511102 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL15517894 | 0.97 | — | — | |
| SCHEMBL9510802 | 0.84 | — | — | |
| SCHEMBL3046515 | 0.78 | FDPS (0.31) | — | |
| SCHEMBL6229100 | 0.76 | — | — | |
| Phosphonic Acid SCHEMBL3924540 | 0.76 | FDPS (0.30) | — | |
| SCHEMBL15570571 | 0.76 | FDPS (0.30) | — | |
| SCHEMBL15572306 | 0.76 | FDPS (0.30) | — | |
| SCHEMBL15572944 | 0.76 | FDPS (0.30) | — | |
| SCHEMBL15571858 | 0.76 | FDPS (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671024-B2 | OBG3 globular head and uses thereof | SERONO GENETICS INSTITUTE S.A. (FR) | 2010-03-02 | — | — | US | disclosed |
| US-20090099076-A1 | OBG3 Globular Head and Uses Thereof | SERONO GENETICS INSTITUTE S.A. (FR) | 2009-04-16 | — | — | US | disclosed |
| US-7393661-B2 | Nucleic acids encoding OBG3 polypeptides | SERONO GENETICS INSTITUTE S.A. (FR) | 2008-07-01 | — | — | US | disclosed |
| US-7338787-B2 | Nucleic acids encoding OBG3 globular head and uses thereof | SERONO GENETICS INSTITUTE S.A. (FR) | 2008-03-04 | — | — | US | disclosed |
| US-20070275891-A1 | OBG3 globular head and uses thereof | GENSET S.A. (FR) | 2007-11-29 | — | — | US | disclosed |
| US-20060293225-A1 | Gmg-2 polynucleotides and polypeptides and uses thereof | GENSET S.A. (FR) | 2006-12-28 | — | — | US | disclosed |
| US-6989367-B2 | OBG3 globular head and uses thereof | GENSET S.A. (FR) | 2006-01-24 | — | — | US | disclosed |
| US-20050079612-A1 | Use of obg3 for promoting central nervous system remyelination | SERONO GENETICS INSTITUTE S.A. (FR) | 2005-04-14 | — | — | US | disclosed |
| US-20050059631-A1 | OBG3 globular head and uses thereof | GENSET S.A. (FR) | 2005-03-17 | — | — | US | disclosed |
| EP-1446143-A2 | USE OF OBG3 FOR PROMOTING CENTRAL NERVOUS SYSTEM REMYELINATION | Genset S.A. (FR) | 2004-08-18 | — | — | EP | disclosed |
| EP-1436392-A2 | GMG-2 POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF | Genset S.A. (FR) | 2004-07-14 | — | — | EP | disclosed |
| US-20040067881-A1 | OBG3 globular head and uses thereof | GENSET S.A. (FR) | 2004-04-08 | — | — | US | disclosed |
| WO-2003051911-A2 | GMG-5 POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF | GENSET S.A. (FR) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003044057-A2 | USE OF OBG3 FOR PROMOTING CENTRAL NERVOUS SYSTEM REMYELINATION | GENSET S.A. (FR) | 2003-05-30 | — | — | WO | disclosed |
| WO-2003010314-A2 | GMG-2 POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF | GENSET S.A. (FR) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003010197-A2 | GMG-1 POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF | GENSET S.A. (FR) | 2003-02-06 | — | — | WO | disclosed |
| US-5543396-A | Proline phosphonate derivatives | GEORGIA TECH RESEARCH CORP. (US) | 1996-08-06 | — | — | US | disclosed |
| WO-1995029691-A1 | PROLINE PHOSPHONATE DERIVATIVES | GEORGIA TECH RESEARCH CORPORATION (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0330353-B1 | TETRAZOLE EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1993-04-07 | — | — | EP | disclosed |
| EP-0330353-A1 | Tetrazole excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1989-08-30 | — | — | EP | disclosed |